●September 7, 2010: JKS News: Taking advantage of the strong Yen, the mid-sized Zeria Shinyaku Kogyo KK continues the acquisition drive and product line expansion: after making Swiss-based Tillotts Pharma AG a wholly-owned subsidiary in 2009, in mid-September Zeria will buy its current Denmark-based Sodium chondroitin sulfates supplier Biofac A/S Esbjerg factory ; announced entering into comprehensive and exclusive contract for domestic development and sales of hemostatic dressing and wound dressing products of Oregon-based HemCon Medical Technologies Inc. introducing to Japan its chitosan-containing medical devices ... Market Access consulting | Zeria products in JAD Databases | related reading
●August 30, 2010: JKS News: The Second Subcommittee of Drugs of PAFSC, MHLW recommended for approval 15 products, including world's first formulations of Shionogi Seiyaku KK Rapiacta (Peramivir) for pediatric use ... Submitted products in JAD Databases
●August 26, 2010: Flu pandemic in Japan (update 12) - preparedness of drugs: Four major pharma makers announced their readiness to supply anti-flu drugs for the 2010/11 season: Chugai Seiyaku KK - Tamiflu for about 12 millions patients; GlaxoSmithKline Japan KK - Relenza for about 6 millions patients; Shionogi Seiyaku KK Rapiacta (Peramivir) for about 1 million patients; and Daiichi-Sankyo KK Inavir for about 1 million patients ... Anti-flu products in JAD Databases | Epidemiology consulting and data
●August 20, 2010: Generics in Japan update: Two of the last major Indian pharma manufacturers not yet presented in Japan - Dr. Reddy's Laboratories Ltd. and Sun Pharmaceutical Industries Ltd. announced plans to enter the expanding market for generics; ● recent Medipeer survey revealed that prescribing physicians most trusted major drug makers (40.5%), domestic generics makers (21.5%), mid-size pharmas (11.3%), against foreign generic manufacturers (1%) ... Generics in JAD Databases | Generics report preview
●August 4, 2010: Cancer update: After the expiration in Japan of Gemzar patent of Nippon Eli Lilly KK 3 generic versions of gemcitabine were launched in July as on August 3rd, a Health Ministry Advisory panel agreed to expand the indications so to include also ovarian cancer ... Related report
●July 26, 2010: Daiichi-Sankyo news update: Daiichi-Sankyo KK sets up a vaccine JV with Kitasato Kenkyujo to produce wide-range of vaccines, including anti-flu vaccines manufactured by cell culture technology; ● further realigns Ranbaxy collaboration: the new drug R&D to be consolidated in the new Daiichi Sankyo Life Science Research Center in Japan, as Ranbaxy to focus of generics; ● sales network of Ranbaxy in Eastern Europe and South Africa to be used for selling Daiichi-Sankyo products ... Daiichi Sankyo products in JAD Databases | Patent expiration and generics consulting
●July 12, 2010: JKS News: The the highly contested general elections ended with complex political balance, future of healthcare still unchartered ... Governmental information
●July 6, 2010: JKS News: After the IHI Plant Engineering KK (of IHI Group) another major machinery manufacturer - Kawasaki Heavy Industries by partnering with the National Center for Child Health and Development and the National Institute of Advanced Industrial Science and Technology (AIST) has entered the advanced biotech field in establishing a method for accelerating the stem cell culturing ... Biotechnology consulting

Archived headline news from other periods could be found here:

• News 2006 - 2013

The JAD News Database is currently in beta-testing and expected to be launched in 2011 for all registered users